All‐trans retinoic acid (Vitamin A) treatment upregulates circHIPK2 during acute promyelocytic leukemia cell differentiation, enhancing miR‐124 activity and MAPK1 downregulation (Li, Ma, et al. 2018). This evidence concerns the gene MAPK1 and acute promyelocytic leukemia.